Disease Characteristics and Treatment Outcomes of Myeloma Patients Under 50 Years of Age: An Analysis of the Balkan Myeloma Study Group

Despina Fotiou; Sorina Bădeliță; Eirini Katodritou; Meral Beksaç; Jelena Bila; Emmanouil Spanoudakis; Josip Batinić; Daniel Coriu; Sinziana Barbu; Catalin Danaı̈la; Dimitra Dalampira; Angeliki Sevastoudi; Güldane Cengiz Seval; Selami Koçak Toprak; Aleksandra Sretenović; Olivera Marković; Toni Valković; Zorica Cvetković; Fenia Theodorakakou; Maria Gavriatopoulou; Evangelos Terpos; Meletios A Dimopoulos; Efstathios Kastritis

doi:10.1016/j.clml.2024.12.017

Related publications

Article2023

P981: DISEASE CHARACTERISTICS AND TREATMENT OUTCOMES OF MYELOMA PATIENTS <50 YEARS OF AGE: AN ANALYSIS OF THE BALKAN MYELOMA STUDY GROUP

Efstathios Kastritis, Meral Beksaç, Sorina Bădeliță, Eirini Katodritou, Jelena Bila, Emmanouil Spanoudakis, Güldane Cengiz Seval, Zorica Cvetković, Daniel Coriu, Milena Mitrović, Carmen Șaguna, Dimitra Dalampira, Anca Bojan, Josip Batinić, Samo Zver, Margarita Guenova, Arben Ivanaj, Maria Gavriatopoulou, Evangelos Terpos, Meletios A Dimopoulos

Article2011

Characteristics and Clinical Course of Myeloma in Patients 40 Years of Age or Younger: A Study of the Greek Myeloma Study Group

Argiris Symeonidis, Efstathios Kastritis, Anastasia Sioni, Sosana Delimpasi, Eirini Katodritou, Eurydiki Michalis, Panagiotis Repousis, Zafiris Kartasis, Nora‐Athina Viniou, Konstantinos Zervas, Evangelos Terpos, Meletios A Dimopoulos

Article2015

Outcomes after Initial Relapse of Multiple Myeloma: An International Myeloma Working Group Study

Shaji Kumar, Jae Hoon Lee, Meletios A Dimopoulos, Evangelos Terpos, Efstathios Kastritis, Wee Joo Chng, Artur Jurczyszyn, Hiroshi Handa, Shuji Ozaki, Xavier Leleu, Philippe Moreau, Juan José Lahuerta, Chaim Shustik, Daniel D. Waller, Meral Beksaç, Ravi Vij, Kihyun Kım, Jin Seok Kim, Ashraf Badros, Melissa Alsina, Brian G.M. Durie

Article2024

Ultra Long-Term Myeloma Survivors (&gt;15 years): Characteristics of a Unique Group of Myeloma Patients

Meletios A Dimopoulos, Despina Fotiou, Foteini Theodorakakou, Eirini Solia, Vasiliki Spiliopoulou, Ioannis Ntanasis‐Stathopoulos, Panagiotis Malandrakis, Erasmia Psimenou, Nikolaos Kanellias, Μαρία Ρούσσου, Magdalini Migkou, Evangelos Eleutherakis‐Papaiakovou, Maria Gavriatopoulou, Evangelos Terpos, Efstathios Kastritis

Article2011

Clinical Features and Outcome of Newly Diagnosed, Symptomatic Patients with Multiple Myeloma ≥80 Years of Age: An Analysis of the Greek Myeloma Study Group

Meletios A Dimopoulos, Efstathios Kastritis, Sosana Delimpasi, Eirini Katodritou, Eleftheria Hatzimichael, Marie‐Christine Kyrtsonis, Panagiotis Repousis, Maria Tsirogianni, Zafiris Kartasis, Agapi Parcharidou, Michalis Michael, Eurydiki Michalis, Dimitra Gika, Argiris Symeonidis, Evangelos Terpos, Konstantinos Zervas

Disease Characteristics and Treatment Outcomes of Myeloma Patients Under 50 Years of Age: An Analysis of the Balkan Myeloma Study Group

Abstract

Discussion(0)

Related publications

P981: DISEASE CHARACTERISTICS AND TREATMENT OUTCOMES OF MYELOMA PATIENTS <50 YEARS OF AGE: AN ANALYSIS OF THE BALKAN MYELOMA STUDY GROUP

Characteristics and Clinical Course of Myeloma in Patients 40 Years of Age or Younger: A Study of the Greek Myeloma Study Group

Outcomes after Initial Relapse of Multiple Myeloma: An International Myeloma Working Group Study

Ultra Long-Term Myeloma Survivors (&gt;15 years): Characteristics of a Unique Group of Myeloma Patients

Clinical Features and Outcome of Newly Diagnosed, Symptomatic Patients with Multiple Myeloma ≥80 Years of Age: An Analysis of the Greek Myeloma Study Group

Disease Characteristics and Treatment Outcomes of Myeloma Patients Under 50 Years of Age: An Analysis of the Balkan Myeloma Study Group

Abstract

Discussion(0)

Related publications

P981: DISEASE CHARACTERISTICS AND TREATMENT OUTCOMES OF MYELOMA PATIENTS &lt;50 YEARS OF AGE: AN ANALYSIS OF THE BALKAN MYELOMA STUDY GROUP

Characteristics and Clinical Course of Myeloma in Patients 40 Years of Age or Younger: A Study of the Greek Myeloma Study Group

Outcomes after Initial Relapse of Multiple Myeloma: An International Myeloma Working Group Study

Ultra Long-Term Myeloma Survivors (&amp;gt;15 years): Characteristics of a Unique Group of Myeloma Patients

Clinical Features and Outcome of Newly Diagnosed, Symptomatic Patients with Multiple Myeloma ≥80 Years of Age: An Analysis of the Greek Myeloma Study Group

P981: DISEASE CHARACTERISTICS AND TREATMENT OUTCOMES OF MYELOMA PATIENTS <50 YEARS OF AGE: AN ANALYSIS OF THE BALKAN MYELOMA STUDY GROUP

Ultra Long-Term Myeloma Survivors (>15 years): Characteristics of a Unique Group of Myeloma Patients